Dr. Imran Arif, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 318
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
OH license 35 089659 -
Cardiovascular Disease Physician
OH license 35-089659 · WV license 20933 -
Internal Medicine Physician
OH license 35-089659 · WV license 20933 -
Nuclear Cardiology Physician
WV license 20933
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Cincinnati Medical Center, LLC Cincinnati, OH
- West Chester Hospital West Chester, OH
Medical groups
- University of Cincinnati Physicians Company LLC (1,506 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 318
- Services billed
- 677
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 139 | 127 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 101 | 95 |
| Established patient office or other outpatient visit, 40-54 minutes | 84 | 65 |
| Critical care, first 30-74 minutes | 58 | 26 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 46 | 18 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | 37 |
| Insertion of tube in right heart chambers for measurement | 35 | 32 |
| New patient office or other outpatient visit, 60-74 minutes | 25 | 25 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | 14 |
| Replacement of aortic valve through the skin and femoral artery | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Cincinnati, OH | 307 |
| Metoprolol Succinate Other prescribers in Cincinnati, OH | 280 |
| Rosuvastatin Calcium Other prescribers in Cincinnati, OH | 159 |
| Carvedilol Other prescribers in Cincinnati, OH | 151 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Cincinnati, OH | 143 |
| Losartan Potassium Other prescribers in Cincinnati, OH | 137 |
| Eliquis (apixaban) Other prescribers in Cincinnati, OH | 137 |
| Furosemide Other prescribers in Cincinnati, OH | 133 |
| Amlodipine Besylate Other prescribers in Cincinnati, OH | 129 |
| Entresto (sacubitril/valsartan) Other prescribers in Cincinnati, OH | 95 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 21 payments worth $1,319 in total to this clinician.
| Aop Health US, LLC | $761 |
|---|---|
| Edwards Lifesciences Corporation | $117 |
| Imperative Care, Inc | $77.14 |
| Abiomed | $64.87 |
| Boston Scientific Corporation | $55.47 |
| Stryker Corporation | $50.40 |
| Chiesi USA, Inc. | $35.13 |
| Zoll Circulation Inc | $30.41 |
| Food and Beverage | $1,319 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $10,768 in research payments for these studies, mostly to the institutions running them.
- NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.